Europe PMC requires Javascript to function effectively.

Either your web browser doesn't support Javascript or it is currently turned off. In the latter case, please turn on Javascript support in your web browser and reload this page.

Search life-sciences literature (45,103,589 articles, preprints and more)

Search results

1-25 of 88 results

Sort by:

Relevance ^{Relevance: This is determined based on a ranking of criteria including term frequency, rarity of term, recency of article, whether there is a Title or Author field match, etc.}

Times cited

Date

1 2 3 Next ...

Mini-consolidations or intermediate-dose cytarabine for the post-remission therapy of AML patients over 60. A retrospective study from the DATAML and SAL registries.
Récher C, Dumas PY, Bérard E, Tavitian S, Leguay T, Galtier J, Alric C, Bidet A, Delabesse E, Rieu JB, Vial JP, Vergez F, Luquet I, Klein E, de Grande AC, Sarry A, Zukunft S, Platzbecker U, Müller-Tidow C, [...] Röllig C
Am J Hematol, 18 Nov 2024
Cited by: 0 articles | PMID: 39555737
Add to export list
Mini-consolidations or intermediate-dose cytarabine (IDAC) for the post-remission therapy of AML patients over 60. A retrospective study from the DATAML and SAL registries.
Récher C, Dumas P, Bérard E, Tavitian S, Leguay T, GALTIER J, Alric C, Bidet A, Delabesse E, Jean-Baptiste R, VIAL J, Vergez F, Luquet I, Klein E, De Grande A, Sarry A, Zukunft S, Platzbecker U, Müller-Tidow C, [...] Röllig C
Research Square, 10 Jun 2024
Cited by: 0 articles | PPR: PPR864956
Add to export list Preprint v1
Imatinib with intensive chemotherapy in AML with t(9;22)(q34.1;q11.2)/BCR::ABL1. A DATAML registry study.
Gondran C, Dumas PY, Bérard E, Bidet A, Delabesse E, Tavitian S, Leguay T, Huguet F, Borel C, Forcade E, Vergez F, Vial JP, Rieu JB, Lechevalier N, Luquet I, Canali A, Klein E, Sarry A, de Grande AC, [...] Bertoli S
Blood Cancer J, 14(1):91, 31 May 2024
Cited by: 1 article | PMID: 38821940 | PMCID: PMC11143277
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Imatinib with intensive chemotherapy in AML with t(9;22)(q34.1;q11.2)/BCR::ABL1. A DATAML registry study.
Récher C, Gondran C, Dumas P, BERARD E, Bidet A, DELABESSE E, Tavitian S, Leguay T, Huguet F, Borel C, Forcade E, Vergez F, VIAL J, [email protected] JB, LECHEVALIER N, LUQUET I, Canali A, KLEIN E, Sarry A, [...] Bertoli S
Research Square, 09 Apr 2024
Cited by: 0 articles | PPR: PPR834806
Add to export list Preprint v1
Artificial intelligence-based prediction models for acute myeloid leukemia using real-life data: A DATAML registry study.
Didi I, Alliot JM, Dumas PY, Vergez F, Tavitian S, Largeaud L, Bidet A, Rieu JB, Luquet I, Lechevalier N, Delabesse E, Sarry A, De Grande AC, Bérard E, Pigneux A, Récher C, Simoncini D, Bertoli S
Leuk Res, 136:107437, 09 Jan 2024
Cited by: 0 articles | PMID: 38215555
Add to export list
Dismal outcome of refractory or relapsing patients with myelodysplasia-related acute myeloid leukemia partially alleviated by intensive chemotherapy.
Leroy H, Gadaud N, Bérard E, Klein E, Luquet I, Vial JP, Rieu JB, Lechevalier N, Tavitian S, Leguay T, Largeaud L, Bidet A, Delabesse E, Sarry A, de Grande AC, Récher C, Pigneux A, Bertoli S, Dumas PY
Cancer Med, 13(3):e7003, 01 Feb 2024
Cited by: 1 article | PMID: 38400682 | PMCID: PMC10891460
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Stem cell-like reprogramming is required for leukemia-initiating activity in B-ALL.
Fregona V, Bayet M, Bouttier M, Largeaud L, Hamelle C, Jamrog LA, Prade N, Lagarde S, Hebrard S, Luquet I, Mansat-De Mas V, Nolla M, Pasquet M, Didier C, Khamlichi AA, Broccardo C, Delabesse É, Mancini SJC, Gerby B
J Exp Med, 221(1):e20230279, 06 Nov 2023
Cited by: 1 article | PMID: 37930337 | PMCID: PMC10626194
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Vitamin C and D supplementation in acute myeloid leukemia.
Mouchel PL, Bérard E, Tavitian S, Gadaud N, Vergez F, Rieu JB, Luquet I, Sarry A, Huguet F, Largeaud L, Delabesse E, Huynh A, Bertoli S, Récher C
Blood Adv, 7(22):6886-6897, 01 Nov 2023
Cited by: 2 articles | PMID: 37671973 | PMCID: PMC10685150
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Cytogenetics in the management of acute myeloid leukemia and histiocytic/dendritic cell neoplasms: Guidelines from the Groupe Francophone de Cytogénétique Hématologique (GFCH).
Bidet A, Quessada J, Cuccuini W, Decamp M, Lafage-Pochitaloff M, Luquet I, Lefebvre C, Tueur G, Groupe Francophone de Cytogénétique Hématologique (GFCH)
Curr Res Transl Med, 71(4):103421, 16 Oct 2023
Cited by: 0 articles | PMID: 38016419
Add to export list Review
Cytogenetics in the management of T-cell acute lymphoblastic leukemia (T-ALL): Guidelines from the Groupe Francophone de Cytogénétique Hématologique (GFCH).
De Bie J, Quessada J, Tueur G, Lefebvre C, Luquet I, Toujani S, Cuccuini W, Lafage-Pochitaloff M, Michaux L
Curr Res Transl Med, 71(4):103431, 01 Oct 2023
Cited by: 1 article | PMID: 38016418
Add to export list
Cytogenetics in the management of B-cell acute lymphoblastic leukemia: Guidelines from the Groupe Francophone de Cytogénétique Hématologique (GFCH).
Tueur G, Quessada J, De Bie J, Cuccuini W, Toujani S, Lefebvre C, Luquet I, Michaux L, Lafage-Pochitaloff M
Curr Res Transl Med, 71(4):103434, 01 Oct 2023
Cited by: 0 articles | PMID: 38064905
Add to export list
Somatic genetic alterations predict hematological progression in GATA2 deficiency.
Largeaud L, Collin M, Monselet N, Vergez F, Fregona V, Larcher L, Hirsch P, Duployez N, Bidet A, Luquet I, Bustamante J, Dufrechou S, Prade N, Nolla M, Hamelle C, Tavitian S, Habib C, Meynier M, Bellanne-Chantelot C, [...] Pasquet M
Haematologica, 108(6):1515-1529, 01 Jun 2023
Cited by: 8 articles | PMID: 36727400
Add to export list
Prognostic Impact of Unsupervised Early Assessment of Bulk and Leukemic Stem Cell Measurable Residual Disease in Acute Myeloid Leukemia.
Canali A, Vergnolle I, Bertoli S, Largeaud L, Nicolau ML, Rieu JB, Tavitian S, Huguet F, Picard M, Bories P, Vial JP, Lechevalier N, Béné MC, Luquet I, Mansat-De Mas V, Delabesse E, Récher C, Vergez F
Clin Cancer Res, 29(1):134-142, 01 Jan 2023
Cited by: 8 articles | PMID: 36318706
Add to export list
The presence of a chromosomal abnormality in cytopenia without dysplasia identifies a category of high-risk clonal cytopenia of unknown significance.
Brett VE, Lechevalier N, Trimoreau F, Dussiau C, Dimicoli-Salazar S, Coster L, Luquet I, Nadal N, Ribourtout B, Chapiro E, Lefebvre C, Tondeur S, Balducci E, Nguyen-Khac F, Borie C, Radford-Weiss I, Barin C, Eclache V, Mansier O, [...] Groupe Francophone de Cytogénétique Hématologique (GFCH)
Genes Chromosomes Cancer, 62(3):139-151, 30 Nov 2022
Cited by: 1 article | PMID: 36412977
Add to export list
Phenotypically-defined stages of leukemia arrest predict main driver mutations subgroups, and outcome in acute myeloid leukemia.
Vergez F, Largeaud L, Bertoli S, Nicolau ML, Rieu JB, Vergnolle I, Saland E, Sarry A, Tavitian S, Huguet F, Picard M, Vial JP, Lechevalier N, Bidet A, Dumas PY, Pigneux A, Luquet I, Mansat-De Mas V, Delabesse E, [...] Récher C
Blood Cancer J, 12(8):117, 16 Aug 2022
Cited by: 7 articles | PMID: 35973983 | PMCID: PMC9381519
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
The complex karyotype in hematological malignancies: a comprehensive overview by the Francophone Group of Hematological Cytogenetics (GFCH).
Nguyen-Khac F, Bidet A, Daudignon A, Lafage-Pochitaloff M, Ameye G, Bilhou-Nabéra C, Chapiro E, Collonge-Rame MA, Cuccuini W, Douet-Guilbert N, Eclache V, Luquet I, Michaux L, Nadal N, Penther D, Quilichini B, Terre C, Lefebvre C, Troadec MB, Véronèse L
Leukemia, 36(6):1451-1466, 16 Apr 2022
Cited by: 6 articles | PMID: 35430613
Add to export list Review
Genomic landscape of hyperleukocytic acute myeloid leukemia.
Largeaud L, Bertoli S, Bérard E, Tavitian S, Picard M, Dufrechou S, Prade N, Vergez F, Rieu JB, Luquet I, Sarry A, Huguet F, Ruiz J, De Mas V, Delabesse E, Récher C
Blood Cancer J, 12(1):4, 05 Jan 2022
Cited by: 4 articles | PMID: 34987148 | PMCID: PMC8733030
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Azacitidine, intensive chemotherapy or best supportive care in relapsed or refractory acute myeloid leukemia, a DATAML registry study.
Gadaud N, Leroy H, Bérard E, Tavitian S, Leguay T, Dimicoli-Salazar S, Rieu JB, Luquet I, Largeaud L, Bidet A, Delabesse E, Klein E, Sarry A, de Grande AC, Bories P, Pigneux A, Récher C, Dumas PY, Bertoli S
Leuk Lymphoma, 63(6):1398-1406, 04 Jan 2022
Cited by: 1 article | PMID: 35634787
Add to export list
The CADM1 tumor suppressor gene is a major candidate gene in MDS with deletion of the long arm of chromosome 11.
Lafage-Pochitaloff M, Gerby B, Baccini V, Largeaud L, Fregona V, Prade N, Juvin PY, Jamrog L, Bories P, Hébrard S, Lagarde S, Mansat-De Mas V, Dovey OM, Yusa K, Vassiliou GS, Jansen JH, Tekath T, Rombaut D, Ameye G, [...] Delabesse E
Blood Adv, 6(2):386-398, 01 Jan 2022
Cited by: 1 article | PMID: 34638130 | PMCID: PMC8791575
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Intermediate-dose cytarabine or standard-dose cytarabine plus single-dose anthracycline as post-remission therapy in older patients with acute myeloid leukemia: impact on health care resource consumption and outcomes.
Galtier J, Alric C, Bérard E, Leguay T, Tavitian S, Bidet A, Delabesse E, Rieu JB, Vial JP, Vergez F, Lechevalier N, Luquet I, Klein E, de Grande AC, Sarry A, Pigneux A, Récher C, Bertoli S, Dumas PY
Blood Cancer J, 11(11):180, 13 Nov 2021
Cited by: 1 article | PMID: 34775463 | PMCID: PMC8590686
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Characteristic vacuolization of myeloid precursors and UBA1 mutation in a woman with monosomy X.
Luquet I, El Kassir A, Sailler L, Largeaud L, Mansat-De Mas V
Int J Lab Hematol, 44(1):29-30, 10 Jun 2021
Cited by: 2 articles | PMID: 34111334
Add to export list
Optical genome mapping, a promising alternative to gold standard cytogenetic approaches in a series of acute lymphoblastic leukemias.
Lestringant V, Duployez N, Penther D, Luquet I, Derrieux C, Lutun A, Preudhomme C, West M, Ouled-Haddou H, Devoldere C, Marolleau JP, Garçon L, Jedraszak G, Ferret Y
Genes Chromosomes Cancer, 60(10):657-667, 26 May 2021
Cited by: 32 articles | PMID: 33982372
Add to export list
KMT2A-ARHGEF12, a Therapy Related Fusion with Dismal Prognosis.
Assaf N, Liévin R, Merabet F, Raggueneau V, Osman J, Spentchian M, Kim R, Renosi F, Garnache F, Eclache V, Luquet I, Abascal LC, D’Angiò M, Larghero P, Meyer C, Marschalek R, Rousselot P, Terré C
Research Square, 24 May 2021
Cited by: 0 articles | PPR: PPR345174
Add to export list Preprint v1
Molecular classification and prognosis in younger adults with acute myeloid leukemia and intermediate-risk cytogenetics treated or not by gemtuzumab ozogamycin: Final results of the GOELAMS/FILO acute myeloid leukemia 2006-intermediate-risk trial.
Bouvier A, Hamel JF, Delaunay J, Delabesse E, Dumas PY, Ledoux MP, Peterlin P, Luquet I, Roth Guepin G, Bulabois CE, Gallego Hernanz MP, Guillerm G, Guieze R, Hicheri Y, Simand C, Himberlin C, Hunault-Berger M, Bernard M, Jourdan E, [...] French Innovative Leukemia Organization
Eur J Haematol, 107(1):111-121, 18 Apr 2021
Cited by: 4 articles | PMID: 33765335
Add to export list
Kidney Involvement in Patients With Chronic Myelomonocytic Leukemia or BCR-ABL-Negative Myeloproliferative Neoplasms.
Belliere J, Colombat M, Kounde C, Recher C, Ribes D, Huart A, Chauveau D, Demas V, Luquet I, Beyne-Rauzy O, Tavitian S, Faguer S
Kidney Int Rep, 6(3):737-745, 14 Dec 2020
Cited by: 6 articles | PMID: 33732988 | PMCID: PMC7938079
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC

1-25 of 88 results

1 2 3 Next ...

Search life-sciences literature (45,103,589 articles, preprints and more)

Search results

Partnerships & funding